Sales of a new drug for the treatment of erectile dysfunction were launched In South Korea. They have a proven efficacy and a favorable safety profile. The new drug for increasing sexual ability is sold under the trademark Mvix S.
- The composition of Mvix S drug includes a new active pharmaceutical ingredient – Mirodenafil.
- The developer of the new drug for the erectile dysfunction treatment Mvix S (Mirodenafil) is the pharmaceutical company SK Chemicals.
The active ingredient Mirodenafil works exactly as the ingredients Tadalafil and Sildenafil, which make part of the popular pills for the erectile dysfunction treatment, Cialis and Viagra.
The uniqueness of the new drug Mvix S is that it is produced not only in the form of tablets, but also in the form of an oral film that dissolves in your mouth within 10-15 seconds.
Viagra tablets provide approximately the same speed and the effect duration. Therefore, the new drug Mvix S will compete primarily with the famous “blue pills” Viagra, and can not become a real competitor to Cialis tablets, which work for 36 hours.
SK Chemicals has not yet attempted to obtain a marketing authorization for Mvix S (Mirodenafil) in Australia. Therefore, the new drug for restoring the sexual ability is not yet available in Australian pharmacies.